E-LIB Suche - Ergebnisse für: Besemer, B.

1

Real-world analysis of teclistamab in 123 RRMM patients fro..:

Riedhammer, C. ; Bassermann, F. ; Besemer, B....
Leukemia. 38 (2024) 2 - p. 365-371 , 2024

Link: https://doi.org/10.1038/..

2

TECLISTAMAB IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRM..:

Donk, NWCJV ; Popat, R ; Rosiol, L...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S397-S398 , 2023

Link: https://doi.org/10.1016/..

3

P958: REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH R..:

Einsele, H. ; Moreau, P. ; De Stefano, V....
HemaSphere. 6 (2022) - p. 848-849 , 2022

Link: https://doi.org/10.1097/..

4

P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF..:

Popat, R ; Usmani, S ; Garfall, A...
HemaSphere. 6 (2022) - p. 14-14 , 2022

Link: https://doi.org/10.1097/..

5

P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-..:

Popat, R. ; Moreau, P. ; Usmani, S. Z....
HemaSphere. 6 (2022) - p. 812-813 , 2022

Link: https://doi.org/10.1097/..

6

P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS ..:

Usmani, S. Z. ; Mielnik, M. ; Koh, Y....
HemaSphere. 6 (2022) - p. 832-833 , 2022

Link: https://doi.org/10.1097/..

7

P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATME..:

Leypoldt, L. ; Gavriatopoulou, M. ; Besemer, B....
HemaSphere. 6 (2022) - p. 816-817 , 2022

Link: https://doi.org/10.1097/..

8

P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASON..:

Mai, E. K. ; Bertsch, U. ; Fenk, R....
HemaSphere. 6 (2022) - p. 820-821 , 2022

Link: https://doi.org/10.1097/..

9

S184: EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/ REF..:

Touzeau, C. ; Krishnan, A. ; Moreau, P....
HemaSphere. 6 (2022) - p. 85-86 , 2022

Link: https://doi.org/10.1097/..

10

Endokrine Veränderungen bei einem jungen Patienten mit meta..:

Heni, M. ; Besemer, B. ; Guthoff, M....
DMW - Deutsche Medizinische Wochenschrift. 138 (2013) 17 - p. 908-908 , 2013

Link: https://doi.org/10.1055/..

11

31-jähriger Patient mit Hodentumor und Hyperthyreose:

Besemer, B. ; Mann, K. ; Horger, M..
Der Internist. 50 (2009) 6 - p. 740-747 , 2009

Link: https://doi.org/10.1007/..

12

P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS ..:

Usmani, S. Z ; Mielnik, M ; Koh, Y...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431311/. , 2022

Link: http://www.ncbi.nlm.nih...

13

P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATME..:

Leypoldt, L ; Gavriatopoulou, M ; Besemer, B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429291/. , 2022

Link: http://www.ncbi.nlm.nih...

14

P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-..:

Popat, R ; Moreau, P ; Usmani, S. Z...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431097/. , 2022

Link: http://www.ncbi.nlm.nih...

15

P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF..:

Popat, R ; Usmani, S ; Garfall, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009794/. , 2022

Link: http://www.ncbi.nlm.nih...